Irritable Bowel Syndrome (IBS) Study
Join us to explore a new treatment option for adults with IBS-D and IBS-M. This study has two parts.
Study site: NeoClinical Research
- Irritable bowel syndrome (IBS)
Recruiting
Male/Female
18 - 80 years of age
TBD
- About the Study
- This study focuses on evaluating a new treatment for adults with IBS-D and IBS-M. It consists of two parts, and after the first part, some participants will be chosen to either get a higher dose or stop the treatment.
- What does the study involve?
- Participants will receive either a placebo (a non-active treatment) or the new treatment.
What to expect
- Placebo
- You may receive a placebo (a look-alike with no active medicine).
- Which treatment you get
- Chosen at random. Neither you nor the study team will know which treatment you get.
- Who can participate?
- We're looking for adults aged 18 to 80 with IBS-D or IBS-M who have had symptoms for at least 6 months. You should have moderate to severe IBS symptoms and experience significant abdominal pain. Think you might qualify? Apply to find out!
Where is the study taking place?
Palmetto Medical Plaza
Study details
- Sponsor
- GlaxoSmithKline
- Phase
- Phase 2: testing whether it works, and its safety, in a larger group
- Dates
- April 2026 to July 2027 (expected)
- Size
- 420 participants across all sites
- Healthy volunteers
- Only people with the condition
Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
One moment…
About NeoClinical Research
NeoClinical Research is a leading, multi-therapeutic clinical research center based in South Florida that bridges the gap between leading pharmaceutical companies and diverse patient populations.